Dilated cardiomyopathy in dogs – what’s new?
Dilated cardiomyopathy (DCM) has historically been a very frustrating disease to diagnose and manage. There is a long pre-clinical phase, where most patients appear asymptomatic, and any clinical abnormalities identifiable on clinical examination are usually subtle and non-specific. Even for those patients that are diagnosed in the pre-clinical phase, most commonly as a result of echocardiography, treatment options that prolong survival time significantly have not been identified. Instead clinicians and owners have been left to watch passively as disease progression results in the development of congestive heart failure and ultimately premature death.
Although the holy grail of a curative medical treatment continues to elude us, there is now a treatment that has been shown to prolong survival time when given to dogs in the pre-clinical phase of this common and devastating disease.
In this article, we will review the clinical features of, and diagnostic options for DCM in dogs, before reviewing updated treatment options.
All our Tutored Online CPD Courses are written and taught by an expert in the relevant field. The tutor for this course is:
Andrew Francis BVSc CertVC DipECVIM (Cardiology) MRCVS European Specialist in Small Animal Cardiology